Cargando…
Recurrent severe hypophosphatemia following intravenous iron administration
Hypophosphatemia postintravenous iron is frequent but under‐recognized. If prolonged or recurrent, it can cause osteomalacia. The likely mechanisms are direct toxicity to proximal tubular cells causing phosphate wasting, elevated Fibroblast growth factor‐23 (FGF‐23), and reduced 1,25‐dihydroxyvitami...
Autores principales: | Nataatmadja, Melissa Stephanie, Francis, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044372/ https://www.ncbi.nlm.nih.gov/pubmed/32128165 http://dx.doi.org/10.1002/ccr3.2595 |
Ejemplares similares
-
Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
por: Hardy, S., et al.
Publicado: (2015) -
Intravenous Iron Induced Severe Hypophosphatemia
por: Guo, Rong R, et al.
Publicado: (2021) -
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
por: Fang, Wendy, et al.
Publicado: (2019) -
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
por: Glaspy, John A., et al.
Publicado: (2021) -
Severe Hypophosphatemia Occurring After Repeated Exposure to a Parenteral Iron Formulation
por: Haridas, Keerthana, et al.
Publicado: (2022)